Navigation Links
Trading of Depomed Common Stock Halted
Date:3/4/2013

NEWARK, Calif., March 4, 2013 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) announced that NASDAQ has halted trading of the company's common stock. The U.S. Food and Drug Administration's (FDA) Reproductive Health Drugs Advisory Committee is meeting this morning to discuss the company's New Drug Application (NDA) for SEFELSA™, Depomed's investigational, oral, twice daily formulation of gabapentin, to treat moderate to severe vasomotor symptoms due to menopause.  SEFELSA is the proposed trade name for the medication and was formerly referred to as Serada.

The Prescription Drug User Fee Act (PDUFA) date for SEFELSA is May 31, 2013.  The PDUFA date is the goal date for the FDA to complete its review of the NDA.

Conference Call

Depomed will host a conference call later today, Monday, March 4 to discuss the Advisory Committee recommendation.  The specific start time for the call will be announced later today.  Participants can access the call by dialing 877-317-6789 (United States) or 412-317-6789 (international). The conference call will also be available via a live webcast on the investor relations section of Depomed's website at http://www.depomed.com. Access the website 15 minutes prior to the start of the call to download and install any necessary audio software. An archived webcast replay will be available on the Company's website for three months.

About Depomed

Depomed, Inc. is a specialty pharmaceutical company with three approved and marketed products. Gralise® (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia (PHN).  Zipsor® (diclofenac potassium) Liquid Filled Capsules is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of mil
'/>"/>

SOURCE Depomed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
2. American Oriental Bioengineering Inc. Announces Suspension of Trading in its Common Stock and the Initiation of Delisting Proceedings by NYSE
3. Trading Of Onyx Pharmaceuticals Common Stock Halted
4. K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the OTC Markets
5. Angeion Announces Name Change and New Trading Symbol Effective Tuesday, August 21, 2012
6. Sae-A Trading Sponsors Medical Mission to Haiti
7. Generex Addresses Recent Trading Volume in Shares of its Common Stock
8. SafeCode Drug Technologies Corp. Begins Trading on the Over-the-Counter Bulletin Board
9. MetaStat Announces Stock Trading on OTC Bulletin Board
10. Vasomedical Common Stock Commences Trading on the OTCBB
11. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 6, 2015  The fairness of the proposed acquisition ... Alexion Pharmaceuticals, Inc. ("Alexion") is being investigated by WeissLaw ... for possible breaches of fiduciary duty and other violations ... for agreeing to sell the Company to Alexion.  On ... for Alexion to acquire GEVA in a transaction valued ...
(Date:5/6/2015)... -- Cardica, Inc. (Nasdaq: CRDC ) today announced financial ... 2015. Cardica,s management will hold a conference call at ... and provide an update on the company,s business. ... fiscal 2015, we reintroduced a modified MicroCutter XCHANGE® 30 ... controlled commercial release is focusing primarily on customers in ...
(Date:5/6/2015)... Corp. (NASDAQ and MTA: CTIC) today reported financial results ... "After reporting positive top-line results from ... the quarter, we have subsequently received positive feedback from ... the potential opportunity for pacritinib to meet a current ... myelofibrosis, specifically in the portion of patients that have ...
Breaking Medicine Technology:WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2Cardica Announces Fiscal 2015 Third Quarter Financial Results 2Cardica Announces Fiscal 2015 Third Quarter Financial Results 3Cardica Announces Fiscal 2015 Third Quarter Financial Results 4Cardica Announces Fiscal 2015 Third Quarter Financial Results 5Cardica Announces Fiscal 2015 Third Quarter Financial Results 6CTI BioPharma Reports First Quarter 2015 Financial Results 2CTI BioPharma Reports First Quarter 2015 Financial Results 3CTI BioPharma Reports First Quarter 2015 Financial Results 4CTI BioPharma Reports First Quarter 2015 Financial Results 5CTI BioPharma Reports First Quarter 2015 Financial Results 6CTI BioPharma Reports First Quarter 2015 Financial Results 7CTI BioPharma Reports First Quarter 2015 Financial Results 8CTI BioPharma Reports First Quarter 2015 Financial Results 9
... Calif., Dec. 20, 2010 Leader Ventures, an investment ... equipment financing to Carmot Therapeutics Inc., an innovative drug ... drug-discovery platform invented by Carmot co-founders Stig K. Hansen ... used to identify promising drug candidates in a broad ...
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) ... of a rolling submission for a Biologics License Application ... for the use of metreleptin to treat diabetes and/or ... patients with rare forms of lipodystrophy. Consistent with the ...
Cached Medicine Technology:Leader Ventures Supports Innovative Drug Discovery Company Carmot 2Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy 2Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy 3Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy 4
(Date:5/6/2015)... (PRWEB) May 06, 2015 The Beryl ... 1 of Patient Experience Journal (PXJ), an international, ... practices around understanding and improving patient experience. The second ... patient experience conversation globally, helps align the voices engaged ... , Published in association with The Beryl Institute, ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as ... latest and coolest applications on the market for iOS, Android, and ... the app review and shared with viewers how this application walks ... to be a good navigator people had to know how to ... is a master navigator. Well what if people could “GPS” their ...
(Date:5/6/2015)... Inversion Studios, a full-service training ... Pilates classes, provides personalized individual instruction and now ... its new Pilates Ring magic circle. , Inversion ... stronger, more centered and graceful, Inversion Studios and ... to healthy fitness through yoga and Pilates. With ...
(Date:5/6/2015)... 06, 2015 Vancouver Chiropractic Clinic, ... their new blog containing the Canadian Physical Activity ... Canadian Society for Exercise Physiology (CSEP). Since the ... health and fitness research and personal training in ... are highly beneficial and a rich resource for ...
(Date:5/6/2015)... Anitoa Systems, (“Anitoa”), a Palo Alto startup established ... successfully demonstrated a handheld real time quantitative-polymerase-chain-reaction system (qPCR) ... qPCR is shown to be capable of detecting several ... C, and E. Coli. This qPCR system has achieved ... 9 orders of magnitude dynamic range. A key ...
Breaking Medicine News(10 mins):Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3
... , MONDAY, Nov. 22 (HealthDay News) -- The pain of ... foot, elbow and lower back pain, a new study has ... osteoarthritis (OA) patients, aged 45 to 79, about pain in ... ankle or foot. Low back pain was significantly associated ...
... the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, ... Award 2010" in the biology category. He will receive ... the understanding of the structure and function of GTP-binding ... two other scientists, Professor Nicolai Cramer (Lausanne, Switzerland) and ...
... , MONDAY, Nov. 22 (HealthDay News) -- If teens, ... could be compromised, a new study suggests. Teens ... providers for fear of being judged, and are reluctant ... to researchers at Cincinnati Children,s Hospital Medical Center. ...
... STANFORD, Calif. Researchers at the Stanford University School ... three-dimensional cancers in a tissue culture dish for the ... divide and invade surrounding tissue will help physicians better ... new technique also provides a way to quickly and ...
... Amounts of Urinary Protein Predict More Rapid Cognitive Decline ... Warranted A new study has found that ... not traditionally considered clinically significant, strongly predict faster cognitive ... 1,200 women aged >70 years in the Nurses, Health ...
... Reporter , FRIDAY, Nov. 19 (HealthDay News) -- Computer imaging ... look after a "nose job," and the majority value the ... "morphing" software, used by plastic surgeons since the 1990s, appears ... said. "Having an image of an individual in front ...
Cached Medicine News:Health News:For Teens, Privacy May Trump Health Care 2Health News:Stanford researchers first to turn normal cells into 3-D cancers in tissue culture dishes 2Health News:Stanford researchers first to turn normal cells into 3-D cancers in tissue culture dishes 3Health News:Protein in the urine: A warning sign for cognitive decline 2Health News:Protein in the urine: A warning sign for cognitive decline 3Health News:Computer Imaging Adds to 'Nose Job' Satisfaction: Study 2Health News:Computer Imaging Adds to 'Nose Job' Satisfaction: Study 3
... Integre Duo is the first ... and green wavelengths. This advanced,laser ... instantly,select either a red or ... maximizes,treatment options and ensures effective,patient ...
... Gathering, managing, and transmitting data ... you were hired for. Dawnings ResultNet/Plus ... running your lab, not your communications ... with transmitting result data from largescale ...
... a comprehensive hemodynamic monitoring and information ... Patient demographics, clinical hemodynamic data, ... information all flow seamlessly into one ... data entry. Both images ...
Exxcel Soft ePTFE vascular graft, designed for exceptional kink resistance and crush resistance, maintains a Soft touch for easier handling during peripheral vascular bypass procedures and vascular a...
Medicine Products: